A new study published in Health Leadership and Quality of Life adds to the growing body of evidence that cannabis can help ease the symptoms of those with multiple sclerosis (MS) and Parkinson’s disease (PD).
Researchers from Anurag University, Chitkara University, and Universidad Nacional de Chimborazo, all in India, surveyed 900 participants, comparing cannabis consumers with non-users across several health measures.
The analysis found that current cannabis users were generally younger and less likely to be classified as obese. Importantly, patients who used cannabis reported reduced levels of emotional variability, improved cognitive function, and lower fatigue scores compared to non-users. These outcomes suggest that cannabis may offer potential benefits in easing some of the neurological and quality-of-life challenges associated with MS and PD.
Researchers used standardized questionnaires to collect information on demographics, physical activity, neurological function, and fatigue. Statistical methods including linear regression, hierarchical regression, and ANCOVA were applied to evaluate the results.
While the findings indicate positive associations between cannabis use and reduced disability in emotional, cognitive, and fatigue domains, the authors say that more research is needed. They emphasize the importance of future longitudinal studies using clinically measured assessments to determine whether these effects are causal and to better understand long-term risks and benefits for MS and PD patients.
More articles from The Marijuana Herald.
